In the case of In re Suboxone Antitrust Litig., the 3rd Circuit affirmed granting class certification to a group who purchased Suboxone from its manufacturer. The class alleged that the manufacturer engaged in unfair trade practice to drive prescribers away from Suboxone tablets and toward under-the-tongue films in order to drive market share away from generic tablet manufacturers.